Join Growin Stock Community!

基米4195.TW Overview

TW StockBiotech. & Medical
(No presentation for 4195)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

基米（4195）Overall Performance

基米（4195）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

基米（4195） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

基米（4195）Key Information

基米（4195）Profile

Genomics BioSci & Tech. Co.,Ltd. operates as a genome sequencing company. It offers regular DNA, complex sequence, and TAF certificated sequencing services, as well as free sequencing primer and primer walking services; peptide, gene, and oligo synthesis services; and sample preparation, gene expression analysis, genotyping analysis, DNA methylation analysis, and microbial identification services. The company also provides genome level, targeted, gene regulation, and metagenomic sequencing services; third generation sequencing services; sequencing platforms and workflow; and non-invasive prenatal test, spinal muscular atrophy carrier screening, and fragile X syndrome premutation screening services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan.

基米（4195）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.51
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
1.99
PB Ratio
2.89
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
29.47%
Net Margin
-28.53%
Revenue Growth (YoY)
8.41%
Profit Growth (YoY)
9.64%
3-Year Revenue Growth
-5.41%
3-Year Profit Growth
-12.25%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.51
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
1.99
PB Ratio
2.89
Price-to-FCF
-
Gross Margin
29.47%
Net Margin
-28.53%
Revenue Growth (YoY)
8.41%
Profit Growth (YoY)
9.64%
3-Year Revenue Growth
-5.41%
3-Year Profit Growth
-12.25%
default symbol

4195

基米

24.45D

-0.82%

(-0.01)

  • When is 4195's latest earnings report released?

    The most recent financial report for 基米 (4195) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4195's short-term business performance and financial health. For the latest updates on 4195's earnings releases, visit this page regularly.

  • What is the operating profit of 4195?

    According to the latest financial report, 基米 (4195) reported an Operating Profit of -31.98M with an Operating Margin of -17.97% this period, representing a growth of 27.29% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4195's revenue growth?

    In the latest financial report, 基米 (4195) announced revenue of 178.01M, with a Year-Over-Year growth rate of 33.63%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4195 have?

    At the end of the period, 基米 (4195) held Total Cash and Cash Equivalents of 92.06M, accounting for 0.07 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4195 go with three margins increasing?

    In the latest report, 基米 (4195) did not achieve the “three margins increasing” benchmark, with a gross margin of 28.07%%, operating margin of -17.97%%, and net margin of 1.4%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4195's profit trajectory and future growth potential.

  • Is 4195's EPS continuing to grow?

    According to the past four quarterly reports, 基米 (4195)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.13. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.